Phreesia, Inc. (PHR) Stock Price & Analysis
Phreesia, Inc. (PHR) fell 1.44% to USD 10.94 as of September 8, 2026 at 10:11 UTC, according to Nexqual real-time market data.
PHR last closed at USD 10.94; the session ranged USD 10.72–11.15 on volume of 807,901 shares. Market capitalization is —, with a 52-week range of USD 7.77–27.11 (NYQ). Source: Nexqual, September 8, 2026 at 10:11 UTC.
Key Statistics (as of September 8, 2026 at 10:11 UTC)
| Price | USD 10.94 |
|---|---|
| Change | ▼ 1.44% (down) |
| Previous Close | USD 10.94 |
| Open | USD 10.94 |
| Day Range | USD 10.72 – 11.15 |
| 52-Week Range | USD 7.77 – 27.11 |
| Volume | 807,901 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (PHR)
Nexqual's technical model rates PHR "NEUTRAL" based on 3 bullish and 4 bearish signals across 128 daily candles, as of September 8, 2026 at 10:11 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 42.28 (neutral) |
| vs SMA50 | Below (USD 11.24) |
| MACD | 0.06 (positive) |
From Phreesia, Inc.'s Latest SEC 10-K Filing (filed 2026-03-31)
Key Strengths & Strategy (as disclosed to the SEC)
- Our Platform and Solutions Phreesia's integrated platform is designed to address challenges patients and healthcare providers face in three core areas: Access, Affordability, and Outcomes.
- We have industry certifications, including HITRUST, PCI-DSS Level 1 Service Provider, Systems and Organization Controls 2 ("SOC 2") and PCI Point-to-Point Encryption.
- Accordingly, new competitors or providers of EHR and PM solutions may emerge that have greater market share, larger client bases, more widely adopted proprietary technologies, greater marketing expertise, new or better AI technologies, greater financial resources and larger sales forces than we have, which could put us at a competitive disadvantage and could render our existing or future products less competitive or obsolete.
- In fiscal year 2026, our platform facilitated approximately 180 million patient visits, representing approximately one in six ambulatory patient visits in the United States.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| HCAT | Health Catalyst, Inc | USD 1.69 | ▲ 0% |
| VCYT | Veracyte, Inc. | USD 42.53 | ▼ 5.24% |
| CSTL | Castle Biosciences, Inc. | USD 32.91 | ▼ 1.53% |
| LOB | Live Oak Bancshares, Inc. | USD 39.61 | ▲ 0.25% |
| HQY | HealthEquity, Inc. | USD 96.07 | ▼ 2.51% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 10:11 UTC. This page is informational and not investment advice.